Journal article · 2021 · Open access

Alternative Methods for Dissolution Profile Comparison in the Dissolution Test

D. P. Romodanovsky, Dmitriy Vladimirovich Goryachev

Drug development & registration, 10(4), 197–207 · Published 25 November 2021 · DOI 10.33380/2305-2066-2021-10-4-197-207

Free PDFView at the publisherCite this paper

In brief

“Alternative Methods for Dissolution Profile Comparison in the Dissolution Test” is a 2021 journal article by D. P. Romodanovsky and Dmitriy Vladimirovich Goryachev, published in Drug development & registration. OpenAlex counts 3 citations as of 16 November 2026. It is open access under a CC BY licence: the full text is free to read at Drug development & registration.

Citations
3
Most cited in
2026 (2)
References
10
Authors
2

Abstract

Introduction. The article discusses the problem of assessing the similarity of the dissolution profiles of two batches of the nebivolol. The use of a generally accepted similarity factor for assessing equivalence is unacceptable in some cases, for example, for drugs with a high variability in the values of the release of the active substance from the formulation. At the same time, at present, there are no generally accepted approaches to comparing the profiles of the dissolution kinetics of drugs, with the exception of the method for assessing the comparability of profiles based on the mathematical calculation of the similarity factor f2, which has certain criteria that limit its application. Aim. To demonstrate alternative methods for assessing the similarity between the dissolution profiles of two drugs using a practical example. Materials and methods. The results of the comparative dissolution test of two series of nebivolol at a dosage of 5 mg. Five model-independent methods for assessing the equivalence of drug dissolution were used. Statistical data processing was performed using Microsoft Excel software. Results and discussion. The paper presents a practical example of using five alternative model-independent methods for assessing the equivalence of the dissolution profile. An example is used to illustrate the proposed equivalence limits and statistical methodology. Also, various approaches to determining the boundaries of equivalence have been proposed to assess the similarity of the dissolution profiles of an active substance. Conclusion. According to the results of the comparative dissolution test of two batches of nebivolol, it was shown that the use of the similarity factor as a criterion for assessing dissolution profiles led to a false positive result. In such cases, the possibility of using alternative methods for assessing the equivalence of dissolution profiles described in the article, or other methods presented in the scientific literature, should be considered, with a justification of their acceptability in each specific case.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Romodanovsky, D. P., & Goryachev, D. V. (2021). Alternative Methods for Dissolution Profile Comparison in the Dissolution Test. Drug development & registration, 10(4), 197–207. https://doi.org/10.33380/2305-2066-2021-10-4-197-207

MLA 9

Romodanovsky, D. P., and Dmitriy Vladimirovich Goryachev. “Alternative Methods for Dissolution Profile Comparison in the Dissolution Test.” Drug development & registration, vol. 10, no. 4, 2021, pp. 197–207. https://doi.org/10.33380/2305-2066-2021-10-4-197-207.

Chicago

Romodanovsky, D. P. and Dmitriy Vladimirovich Goryachev. 2021. “Alternative Methods for Dissolution Profile Comparison in the Dissolution Test.” Drug development & registration 10 (4): 197–207. https://doi.org/10.33380/2305-2066-2021-10-4-197-207.

Harvard

Romodanovsky, D. P. and Goryachev, D. V. (2021) ‘Alternative Methods for Dissolution Profile Comparison in the Dissolution Test’, Drug development & registration, 10(4), pp. 197–207. doi:10.33380/2305-2066-2021-10-4-197-207.

IEEE

D. P. Romodanovsky and D. V. Goryachev, “Alternative Methods for Dissolution Profile Comparison in the Dissolution Test,” Drug development & registration, vol. 10, no. 4, pp. 197–207, 2021, doi: 10.33380/2305-2066-2021-10-4-197-207.

BibTeX

@article{romodanovsky2021alternative,
  title     = {{Alternative Methods for Dissolution Profile Comparison in the Dissolution Test}},
  author    = {Romodanovsky, D. P. and Goryachev, Dmitriy Vladimirovich},
  journal   = {Drug development \& registration},
  year      = {2021},
  volume    = {10},
  number    = {4},
  pages     = {197--207},
  doi       = {10.33380/2305-2066-2021-10-4-197-207},
  url       = {https://doi.org/10.33380/2305-2066-2021-10-4-197-207}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals

  • dissolution profile comparison
  • nebivolol
  • bioequivalence assessment
  • model-independent analysis
  • similarity factor f2
  • dissolution kinetics
  • false positives

Work with this paper

Most-cited papers in Chemistry

All highly cited Chemistry papers

Questions about this paper

How do I cite this paper in APA style?

Romodanovsky, D. P., & Goryachev, D. V. (2021). Alternative Methods for Dissolution Profile Comparison in the Dissolution Test. Drug development & registration, 10(4), 197–207. https://doi.org/10.33380/2305-2066-2021-10-4-197-207

How many times has this paper been cited?

3 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Drug development & registration.

Who wrote this paper?

D. P. Romodanovsky, Dmitriy Vladimirovich Goryachev.

What is the DOI of this paper?

10.33380/2305-2066-2021-10-4-197-207. The permanent link is https://doi.org/10.33380/2305-2066-2021-10-4-197-207.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.